Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated to v3.5.2. The previous revision v3.5.0 was removed.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a Publications section with a PubMed citation for the study. Publications are noted as automatically populated from PubMed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check38 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.4.2 was added; the prior notices about funding and government status (v3.4.1) were removed.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a government funding lapse notice about site operation and potential processing delays. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.